U.S. Markets open in 4 hrs 42 mins

United Therapeutics Corporation (UTHR)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
122.57+0.93 (+0.76%)
At close: 4:00PM EDT
People also watch
ALXNBMRNVRTXMDCOMYGN
Currency in USD

Valuation Measures

Market Cap (intraday) 55.52B
Enterprise Value 3N/A
Trailing P/E 8.61
Forward P/E 111.11
PEG Ratio (5 yr expected) 1-0.32
Price/Sales (ttm)3.45
Price/Book (mrq)2.67
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profitability
Profit Margin 41.04%
Operating Margin (ttm)60.09%
Management Effectiveness
Return on Assets (ttm)25.29%
Return on Equity (ttm)34.78%
Income Statement
Revenue (ttm)1.6B
Revenue Per Share (ttm)36.72
Quarterly Revenue Growth (yoy)0.40%
Gross Profit (ttm)1.53B
EBITDA 993.4M
Net Income Avi to Common (ttm)656.8M
Diluted EPS (ttm)14.24
Quarterly Earnings Growth (yoy)-24.20%
Balance Sheet
Total Cash (mrq)1.16B
Total Cash Per Share (mrq)25.66
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.52
Book Value Per Share (mrq)45.84
Cash Flow Statement
Operating Cash Flow (ttm)748.6M
Levered Free Cash Flow (ttm)770.74M

Trading Information

Stock Price History
Beta 1.31
52-Week Change 34.30%
S&P500 52-Week Change 314.72%
52 Week High 3169.89
52 Week Low 397.52
50-Day Moving Average 3122.26
200-Day Moving Average 3138.94
Share Statistics
Avg Vol (3 month) 3632.03k
Avg Vol (10 day) 3428.58k
Shares Outstanding 545.06M
Float 41.09M
% Held by Insiders 11.45%
% Held by Institutions 1113.70%
Shares Short 36.27M
Short Ratio 39.65
Short % of Float 315.58%
Shares Short (prior month) 35.78M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Sep 23, 2009